Home > News > PGI research may help lower drug dosage
July 9th, 2007
PGI research may help lower drug dosage
In future, people suffering from tuberculosis (TB), cardiovasucular diseases, hypertension and other chronic diseases may not have to take drugs daily for the rest of their lives. A path breaking pre-clinical research by a team of doctors at the PGI has established a system of sustained drug delivery through nanotechnology.
The system involves encapsulating the drug in nanoparticles taken from synthetic polymers. This ensures that the drug stays in the plasma and the organs for a longer period. Secondly, since the frequency of taking drugs comes down, lesser drugs are used.
Treatment of Cell Infection by Nanotechnology September 15th, 2014
Researchers Create World’s Largest DNA Origami September 11th, 2014
Iranian Scientists Discover Nanotechnology Method to Remove Limitations in Tumor Surgery September 11th, 2014
Iranian Nanotechnology Scientists Produce Polymeric Scaffolds for Tissue Engineering September 11th, 2014
Dolomite to launch Meros TCU-100 temperature controller at Lab-on-a-Chip & Microarray World Congress September 15th, 2014
Fonon at Cutting-Edge of 3D Military Printing: Live-Combat Scenarios Could See a Decisive Advantage with 3D Printing September 15th, 2014
Rice rolls 'neat' nanotube fibers: Rice University researchers' acid-free approach leads to strong conductive carbon threads September 15th, 2014
Simple, Cost-Effective Method Proposed for Synthesizing Zinc Oxide Nanopigments September 15th, 2014